Interim Chief Medical Officer: Graham Ross MD

Graham Ross trained as an oncologist in Durban, South Africa. He moved to the UK and joined the pharmaceutical industry more than twenty-five years ago. He has worked for companies including GlaxoSmithKline, Roche and Astra-Zeneca; specialising a second time in the UK in pharmaceutical medicine. His career highlight is the clinical development of pertuzumab (Perjeta™) for the treatment, in combination with trastuzumab (Herceptin™), of patients with HER2 positive breast cancer.


Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image
Menu